Muscarinic pharmacology of the inhibition of adenylate cyclase in N18TG2 neuroblastoma cells
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 11 (3) , 287-292
- https://doi.org/10.1016/0197-0186(87)90048-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cellsJournal of Neuroscience Research, 1987
- Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studiesBrain Research, 1986
- Muscarinic Receptors and Hydrolysis of Inositol Phospholipids in Rat Cerebral Cortex and Parotid GlandJournal of Neurochemistry, 1985
- Receptor-Mediated Increases in Phosphatidylinositol Turnover in Neuron-Like Cell LinesJournal of Neurochemistry, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- MUSCARINIC RECEPTORS IN RAT SYMPATHETIC GANGLIABritish Journal of Pharmacology, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- MUSCARINIC REGULATION OF cAMP IN MOUSE NEUROBLASTOMAJournal of Neurochemistry, 1977
- A highly sensitive adenylate cyclase assayAnalytical Biochemistry, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973